Cited by 35Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsHormonal and reproductive studies

Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOM-cohort

Open access
Gorgels, W.J.M.J., Graaf, Y.v.d., Blankenstein, M.A., Collette, H.J.A., Erkelens, D.W., Banga, J.D.·1997·Journal of Clinical Epidemiology

Abstract

The low incidence of coronary heart disease (CHD) in premenopausal women is partly ascribed to protection by endogenous estrogen production. As a consequence, we hypothesized that premenopausal women with low endogenous estrogen production or high androgen production might be at increased risk for CHD. We studied the relationship between urinary sex hormone excretions and CHD risk by means of a nested case-referent study within a cohort of premenopausal (ages 40-49 yrs) women (n = 11,284). This cohort was formed at a breast cancer screening project in 1982-1986 (The Diagnostisch Onderzoek Mammacarcinoom [DOM] Project). Baseline data included self-administered questionnaires and anthropometric measurements. At the time of screening the women were instructed to collect an overnight urine sample on day 22 of three separate cycles. These urine samples were stored at -20 degrees C. Up to June 1991, 45 subjects were admitted to local hospitals on diagnosis of CHD (29 with myocardial infarction, and 16 with angiographically confirmed coronary disease). Referents were sampled from the cohort, matched for age and year of screening in a 1:3 ratio. In a follow-up study, menopausal state of the subjects was assessed yearly by mailed questionnaires. Urinary excretions of estrone-glucuronide, pregnanediol-glucuronide, and testosterone-glucuronide adjusted by creatinine were similar for cases and referents. Cases had no earlier menopause than referents, although cases had more anovulatory cycles. The occurrence of CHD in middle-aged women is not preceded by a low premenopausal endogenous estrogen production or high androgen production. Anovulatory cycles appear more frequently in women who develop CHD many years later.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0895-4356(96)00367-8

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Beard CM, Fuster V, Annegers JF. Reproductive history in women with coronary heart disease. Am J Epidemiol 1984; 120: 108-114.
  2. W HO Task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart dis ease, special report. Circulation 1979; 59: 607-609.

Cited by

Sorted by citations

Authors
Gorgels, W. J. M. J., Graaf, Y. V. D., Blankenstein, M. A., Collette, H. J. A., Erkelens, D. W., & Banga, J. D.
Affiliations
  • Utrecht University (NL)
  • University Medical Center Utrecht (NL)
Corresponding author
Banga, J.D.
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
1997-03
Volume
50
Issue
3
Pages
275-281
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2160043529
Cited by
35
References
21
Citations by year
2026: 1 · 2025: 2 · 2023: 2 · 2022: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
0.47
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
coronary artery disease, premenopausal women, endogenous estrogen, androgens, estrone glucuronide, pregnanediol glucuronide, testosterone glucuronide, myocardial infarction, anovulatory cycles, menopause
MeSH terms
Adult, Anovulation, Coronary Disease, Female, Humans, Middle Aged, Prospective Studies, Risk Factors, Gonadal Steroid Hormones, Case-Control Studies, Coronary Angiography, Premenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review